Changed energy state and increased mitochondrial beta-oxidation rate in liver of rats associated with lowered proton electrochemical potential and stimulated uncoupling protein 2 (UCP-2) expression: evidence for peroxisome proliferator-activated receptor-alpha independent induction of UCP-2 expression.
Lowering of plasma triglyceride levels by hypolipidemic agents is caused by a shift in the liver cellular metabolism, which become poised toward peroxisome proliferator-activated receptor (PPAR) alpha-regulated fatty acid catabolism in mitochondria. After dietary treatment of rats with the hypolipidemic, modified fatty acid, tetradecylthioacetic acid (TTA), the energy state parameters of the liver were altered at the tissue, cell, and mitochondrial levels. Thus, the hepatic phosphate potential, energy charge, and respiratory control coefficients were lowered, whereas rates of oxygen uptake, oxidation of pyridine nucleotide redox pairs, beta-oxidation, and ketogenesis were elevated. Moderate uncoupling of mitochondria from TTA-treated rats was confirmed, as the proton electrochemical potential (Delta(p)) was 15% lower than controls. The change affected the Delta(Psi) component only, leaving the (Delta)pH component unaltered, suggesting that TTA causes induction of electrogenic ion transport rather than electrophoretic fatty acid activity. TTA treatment induced expression of hepatic uncoupling protein 2 (UCP-2) in rats as well as in wild type and PPARalpha-deficient mice, accompanied by a decreased double bond index of the mitochondrial membrane lipids. However, changes of mitochondrial fatty acid composition did not seem to be related to the effects on mitochondrial energy conductance. As TTA activates PPARdelta, we discuss how this subtype might compensate for deficiency of PPARalpha. The overall changes recorded were moderate, making it likely that liver metabolism can maintain its function within the confines of its physiological regulatory framework where challenged by a hypolipemic agent such as TTA, as well as others.
Grav
Hans J
HJ
Institute for Nutrition Research, University of Oslo, N-0316 Oslo, Norway.
Tronstad
Karl J
KJ
Gudbrandsen
Oddrun A
OA
Berge
Kjetil
K
Fladmark
Kari E
KE
Martinsen
Tom C
TC
Waldum
Helge
H
Wergedahl
Hege
H
Berge
Rolf K
RK
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D004041:Dietary Fats / Q000493:pharmacokinetics; D004563:Electrochemistry; D004734:Energy Metabolism / Q000502:physiology*; D005227:Fatty Acids / Q000493:pharmacokinetics; D015870:Gene Expression / Q000187:drug effects; D022781:Hepatocytes / Q000378:metabolism*; D007473:Ion Channels; D008297:Male; D026901:Membrane Transport Proteins; D051379:Mice; D008817:Mice, Mutant Strains; D008930:Mitochondria, Liver / Q000737:chemistry / Q000378:metabolism*; D024101:Mitochondrial Proteins; D010084:Oxidation-Reduction; D011506:Proteins / Q000235:genetics* / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics / Q000378:metabolism; D013440:Sulfides / Q000494:pharmacology; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism; D000071246:Uncoupling Protein 2
D000975:Antioxidants; D004041:Dietary Fats; D005227:Fatty Acids; D007473:Ion Channels; D026901:Membrane Transport Proteins; D024101:Mitochondrial Proteins; D011506:Proteins; D018160:Receptors, Cytoplasmic and Nuclear; D013440:Sulfides; D014157:Transcription Factors; C000604390:Ucp2 protein, mouse; C000604391:Ucp2 protein, rat; D000071246:Uncoupling Protein 2; C062078:1-(carboxymethylthio)tetradecane